1: The SkybriGHt registry study: A US multi-center, prospective, non-interventional, long-term, effectiveness and safety study of children and adolescents with growth hormone deficiency treated with lonapegsomatropin-tcgd.

Autor: Sather, Mako, Brady, Meredith
Zdroj: Journal of Pediatric Nursing; Jul2024, Vol. 77, p247-248, 2p
Databáze: Supplemental Index